Agrawal V, Slivac I, Perret S, Bisson L, St-Laurent G, Murad Y, Zhang J, Durocher Y (2012) Stable expression of chimeric heavy chain antibodies in CHO cells. In: Saerens D, Muyldermans (eds) Single Domain Antibodies: Methods and Protocols, Methods in Molecular Biology, vol 911. Springer, New York, p 287-303.
Bandaranayake A D, Almo S C (2014) Recent advances in mammalian protein production. FEBS letters 588: 253-260.
Bergman L, Harris E, Kuehl W (1981) Glycosylation causes an apparent block in translation of immunoglobulin heavy chain. J Biol Chem 256: 701-706.
Borth N, Strutzenberger K, Kunert R, Steinfellner W, Katinger H (1999) Analysis of changes during subclone development and ageing of human antibody-producing heterohybridoma cells by northern blot and flow cytometry. J Biotech 67: 57-66.
Curigliano G, O’Connor D P, Rosenberg J A, Jacobs I (2016) Biosimilars: extrapolation for oncology. Critical reviews in oncology/hematology 104: 131-137.
Chusainow J, Yang Y S, Yeo J H, Toh P C, Asvadi P, Wong N. S, Yap M G (2009) A study of monoclonal antibody‐producing CHO cell lines: What makes a stable high producer? Biotech and Bioeng 102: 1182-1196.
de la Cruz Edmonds M C, Tellers M, Chan C, Salmon P, Robinson D K, Markusen J (2006) Development of transfection and high-producer screening protocols for the CHOK1SV cell system. Mol biotech 34: 179-190.
Dillman R O (1999) Perceptions of Herceptin®: A monoclonal antibody for the treatment of breast cancer. Cancer biother & radiopharm 14: 5-10.
Dorai H, Corisdeo S, Ellis D, Kinney C, Chomo M, Hawley‐Nelson P, Moore G, Betenbaugh M J, Ganguly S (2012) Early prediction of instability of chinese hamster ovary cell lines expressing recombinant antibodies and antibody‐fusion proteins. Biotech and bioeng 109: 1016-1030.
Dorai H, Csirke B, Scallon B, Ganguly S (2006) Correlation of heavy and light chain mRNA copy numbers to antibody productivity in mouse myeloma production cell lines. Hybridoma 25: 1-9.
Edros R Z, McDonnell S, Al-Rubeai M (2013) Using molecular markers to characterize productivity in Chinese hamster ovary cell lines. PLoS One 8: e75935.
Gaillet B, Gilbert R, Broussau S, Pilotte A, Malenfant F, Mullick A, Garnier A, Massie B (2010) High‐level recombinant protein production in CHO cells using lentiviral vectors and the cumate gene‐switch. Biotech and bioeng 106: 203-215.
Genentech (1998). Herceptin prescribing.
Gödecke N, Hauser H, Wirth D (2018) Stable Expression by Lentiviral Transduction of Cells. In: Hacker D (ed) Recombinant Protein Expression in Mammalian Cells. Methods and Protocols. Springer, New York, p 43-55.
Hacker D L, Balasubramanian S (2016) Recombinant protein production from stable mammalian cell lines and pools. Curr Opin Struct Biol 38: 129-136.
Heffner K, Kaas C S, Kumar A, Baycin-Hizal D, Betenbaugh M (2015) Proteomics in Cell Culture: From Genomics to Combined ‘Omics for Cell Line Engineering and Bioprocess Development. In Animal Cell Culture. Springer, New York, p 591-614.
Ho S C, Bardor M, Feng H, Tong Y W, Song Z, Yap M G, Yang Y (2012) IRES-mediated Tricistronic vectors for enhancing generation of high monoclonal antibody expressing CHO cell lines. J Biotech 157: 130-139.
Ho S C, Koh E Y, van Beers M, Mueller M, Wan C, Teo G (2013) Control of IgG LC: HC ratio in stably transfected CHO cells and study of the impact on expression, aggregation, glycosylation and conformational stability. J Biotech 165: 157-166.
Hutterer K M, Polozova A, Kuhns S, McBride H J, Cao X; Liu J (2019) Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab. BioDrugs. DOI: 10.1080/19420862.2017.1305530.
Jiang Z, Huang Y, Sharfstein S T (2006) Regulation of Recombinant Monoclonal Antibody Production in Chinese Hamster Ovary Cells: A Comparative Study of Gene Copy Number, mRNA Level, and Protein Expression. Biotechn Prog 22: 313-318.
Jostock T (2011) Expression of antibody in mammalian cells. In: Al-Rubeai M (ed) Antibody Expression and Production. Cell Engineering, vol 7. Springer, p 1-24.
Kim J Y, Kim Y G, Lee G M (2012) CHO cells in biotechnology for production of recombinant proteins: current state and further potential. App Microbiol Biotech 93: 917-930.
Kim S, Song J, Park S, Ham S, Paek K, Kang M, Chae Y, Seo H, Kim H, Flores M (2017) Drifts in ADCC-related quality attributes of Herceptin®: Impact on development of a trastuzumab biosimilar. mAbs 9: 704-714.
Kober L, Zehe C, Bode J (2013) Optimized signal peptides for the development of high expressing CHO cell lines. Biotech and Bioeng 110: 1164-1173.
Krebs L E, Bowden D M, Bray C M, Shaw M M, Frye C C (2018) Effective and efficient characterization of Chinese hamster ovary production cell lines using automated intracellular staining and statistical modeling. Biotechn Prog 34: 570-583.
Kuystermans D, Al-Rubeai M (2015a) Biopharmaceutical products from animal cell culture. In: Al-Rubeai M (ed) Animal Cell Culture, vol 9. Springer, New York, p 717-757.
Kuystermans D, Al-Rubeai M (2015b) Mammalian cell line selection strategies for high-producers. In: Al-Rubeai M (ed) Animal Cell Culture, vol 9. Springer, New York, p 327-372.
Laemmli U K (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
Lattenmayer C, Trummer E, Schriebl K, Vorauer-Uhl K, Mueller D, Katinger H, Kunert R (2007) Characterisation of recombinant CHO cell lines by investigation of protein productivities and genetic parameters. J Biotech 128: 716-725.
Le Fourn V, Girod P A, Buceta M, Regamey A, Mermod N (2014) CHO cell engineering to prevent polypeptide aggregation and improve therapeutic protein secretion. Metabolic Engin 21: 91-102.
Lee C J, Seth G, Tsukuda J, Hamilton R W (2009) A clone screening method using mRNA levels to determine specific productivity and product quality for monoclonal antibodies. Biotech and Bioeng 102: 1107-1118.
Lee G M C, Alice S, Palsson B (1993) Effect of fixation temperature on flow cytometric measurement of intracellular antibody content of hybridomas during batch culture. Biotech Techn 7: 271-276.
Li F, Vijayasankaran N, Shen A, Kiss R, Amanullah A (2010) Cell culture processes in monoclonal antibody production. mAbs 2: 466-479.
McDonnell, S. (2015). Production of antibodies in hybridoma and non-hybridoma cell lines. In: Al-Rubeai M (ed) Animal Cell Culture, vol 9. Springer, New York, p 65-88.
Mora A, Zhang S, Carson G, Nabiswa B, Hossler P, Yoon S (2018) Sustaining an efficient and effective CHO cell line development platform by incorporation of 24‐deep well plate screening and multivariate analysis. Biotech Prog 34: 175-186.
Mursi, I. F. A., and Masuda, S. (2018). The Production of Recombinant Proteins from Mammalian Cells Using RNA Element. In: Masuda S, Izawa S (eds) Applied RNA Bioscience. Springer, Singapore, p 131-150.
Springer Nature Singapore Pte Ltd. 2018
S. Masuda, S. Izawa (eds.), Applied RNA Bioscience
Nelson K G, PC (2014) Biosimilars lining up to compete with Herceptin--opportunity knocks. Expert Opin Ther Pat 24: 1149-1153.
Noh S M, Shin S, Lee G M (2018) Comprehensive characterization of glutamine synthetase-mediated selection for establishment of recombinant CHO cells producing monoclonal antibodies. Scientific reports 8: 1-11.
Oberbek A, Matasci M, Hacker D L, Wurm F M (2011) Generation of stable, high‐producing cho cell lines by lentiviral vector‐mediated gene transfer in serum‐free suspension culture. Biotech and Bioeng 108: 600-610.
Paplomata E, Nahta R (2018) ABP 980: promising trastuzumab biosimilar for HER2-positive breast cancer. Expert Opin Biol therapy 18: 335-341.
Park S H, Ryu D D (1994) Cell cycle kinetics and monoclonal antibody productivity of hybridoma cells during perfusion culture. Biotech and Bioeng 44: 361-367.
Pivot X, Petit T (2018) Can we establish a hierarchy among trastuzumab biosimilar candidates? British J Cancer 119:263–265.
Porter A J, Racher A J, Preziosi R, Dickson A J (2010) Strategies for selecting recombinant CHO cell lines for cGMP manufacturing: improving the efficiency of cell line generation. Biotech Prog 26: 1455-1464.
Priola J J, Calzadilla N, Baumann M, Borth N, Tate C G, Betenbaugh M J (2016) High‐throughput screening and selection of mammalian cells for enhanced protein production. Biotech J 11: 853-865.
Roy G, Miro-Quesada G, Zhuang L, Martin T, Zhu J, Wu H, Marelli M, Bowen M A (2017) Sequential screening by ClonePix FL and intracellular staining facilitate isolation of high producer cell lines for monoclonal antibody manufacturing. J Immunol Methods 451: 100-110.
Schlatter S, Stansfield S H, Dinnis D M, Racher A J, Birch J R, James D C (2005) On the optimal ratio of heavy to light chain genes for efficient recombinant antibody production by CHO cells. Biotech Prog 21: 122-133.
Toledo J R, Prieto Y, Oramas N, Sánchez O (2009) Polyethylenimine-based transfection method as a simple and effective way to produce recombinant lentiviral vectors. App Biochem Biotech 157: 538-544.
Wurm F M, de Jesus M (2016) Manufacture of Recombinant Therapeutic Proteins Using Chinese Hamster Ovary Cells in Large‐Scale Bioreactors. History, Methods, and Perspectives. In: Liu Ch, Morrow J (eds) Biosimilars of Monoclonal Antibodies: A Practical Guide to Manufacturing, Preclinical, and Clinical Development, John Wiley & Sons, Inc., p 327-353.